Annual FCF
$7.36 B
-$1.43 B-16.23%
31 December 2023
Summary:
Amgen annual free cash flow is currently $7.36 billion, with the most recent change of -$1.43 billion (-16.23%) on 31 December 2023. During the last 3 years, it has fallen by -$2.53 billion (-25.58%). AMGN annual FCF is now -30.30% below its all-time high of $10.56 billion, reached on 31 December 2018.AMGN Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
$3.31 B
+$1.09 B+49.21%
30 September 2024
Summary:
Amgen quarterly free cash flow is currently $3.31 billion, with the most recent change of +$1.09 billion (+49.21%) on 30 September 2024. Over the past year, it has increased by +$802.00 million (+31.93%). AMGN quarterly FCF is now -13.65% below its all-time high of $3.84 billion, reached on 30 June 2023.AMGN Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
$6.28 B
+$802.00 M+14.63%
30 September 2024
Summary:
Amgen TTM free cash flow is currently $6.28 billion, with the most recent change of +$802.00 million (+14.63%) on 30 September 2024. Over the past year, it has dropped by -$3.10 billion (-33.01%). AMGN TTM FCF is now -42.19% below its all-time high of $10.87 billion, reached on 31 March 2018.AMGN TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMGN Free Cash Flow Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -16.2% | +31.9% | -33.0% |
3 y3 years | -25.6% | +52.3% | -19.9% |
5 y5 years | -30.3% | +3.3% | -31.5% |
AMGN Free Cash Flow High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -25.6% | at low | -13.7% | +1046.7% | -35.1% | +14.6% |
5 y | 5 years | -30.3% | at low | -13.7% | +1046.7% | -38.6% | +14.6% |
alltime | all time | -30.3% | >+9999.0% | -13.7% | +4639.7% | -42.2% | >+9999.0% |
Amgen Free Cash Flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $3.31 B(+49.2%) | $6.28 B(+14.6%) |
June 2024 | - | $2.22 B(+383.9%) | $5.48 B(-22.8%) |
Mar 2024 | - | $459.00 M(+58.8%) | $7.10 B(-3.5%) |
Dec 2023 | $7.36 B(-16.2%) | $289.00 M(-88.5%) | $7.36 B(-21.5%) |
Sept 2023 | - | $2.51 B(-34.5%) | $9.38 B(-3.2%) |
June 2023 | - | $3.84 B(+433.1%) | $9.69 B(+28.6%) |
Mar 2023 | - | $720.00 M(-68.8%) | $7.53 B(-14.3%) |
Dec 2022 | $8.79 B(+4.8%) | $2.31 B(-18.1%) | $8.79 B(-2.4%) |
Sept 2022 | - | $2.82 B(+67.3%) | $9.00 B(+7.7%) |
June 2022 | - | $1.68 B(-14.7%) | $8.36 B(-0.7%) |
Mar 2022 | - | $1.97 B(-21.7%) | $8.42 B(+0.4%) |
Dec 2021 | $8.38 B(-15.2%) | $2.52 B(+15.9%) | $8.38 B(+6.9%) |
Sept 2021 | - | $2.18 B(+24.6%) | $7.84 B(-11.9%) |
June 2021 | - | $1.75 B(-9.9%) | $8.90 B(-9.5%) |
Mar 2021 | - | $1.94 B(-2.1%) | $9.84 B(-0.5%) |
Dec 2020 | $9.89 B(+15.9%) | $1.98 B(-38.8%) | $9.89 B(-3.4%) |
Sept 2020 | - | $3.23 B(+20.5%) | $10.23 B(+0.3%) |
June 2020 | - | $2.68 B(+34.7%) | $10.21 B(+16.1%) |
Mar 2020 | - | $1.99 B(-14.4%) | $8.79 B(+3.1%) |
Dec 2019 | $8.53 B(-19.2%) | $2.33 B(-27.5%) | $8.53 B(-7.0%) |
Sept 2019 | - | $3.21 B(+152.5%) | $9.18 B(+1.2%) |
June 2019 | - | $1.27 B(-26.5%) | $9.07 B(-6.6%) |
Mar 2019 | - | $1.73 B(-41.8%) | $9.71 B(-8.0%) |
Dec 2018 | $10.56 B(+0.4%) | $2.97 B(-4.3%) | $10.56 B(+1.1%) |
Sept 2018 | - | $3.10 B(+62.0%) | $10.45 B(-1.8%) |
June 2018 | - | $1.92 B(-25.5%) | $10.64 B(-2.1%) |
Mar 2018 | - | $2.57 B(-10.0%) | $10.87 B(+3.4%) |
Dec 2017 | $10.51 B(+9.3%) | $2.86 B(-13.3%) | $10.51 B(-0.1%) |
Sept 2017 | - | $3.30 B(+53.9%) | $10.53 B(+7.1%) |
June 2017 | - | $2.14 B(-3.4%) | $9.82 B(-2.5%) |
Mar 2017 | - | $2.22 B(-22.8%) | $10.07 B(+4.8%) |
Dec 2016 | $9.62 B(+5.2%) | $2.87 B(+10.8%) | $9.62 B(+11.7%) |
Sept 2016 | - | $2.59 B(+8.5%) | $8.61 B(-2.4%) |
June 2016 | - | $2.39 B(+35.9%) | $8.82 B(-7.5%) |
Mar 2016 | - | $1.76 B(-5.8%) | $9.53 B(+4.3%) |
Dec 2015 | $9.14 B(+14.9%) | $1.87 B(-33.4%) | $9.14 B(-6.5%) |
Sept 2015 | - | $2.80 B(-9.6%) | $9.77 B(+4.1%) |
June 2015 | - | $3.10 B(+127.3%) | $9.39 B(+12.5%) |
Mar 2015 | - | $1.36 B(-45.5%) | $8.34 B(+5.0%) |
Dec 2014 | $7.95 B(+42.0%) | $2.50 B(+3.4%) | $7.95 B(+12.3%) |
Sept 2014 | - | $2.42 B(+17.9%) | $7.08 B(+12.5%) |
June 2014 | - | $2.05 B(+111.8%) | $6.29 B(+10.8%) |
Mar 2014 | - | $970.00 M(-40.6%) | $5.68 B(+1.4%) |
Dec 2013 | $5.60 B(+8.3%) | $1.63 B(+0.1%) | $5.60 B(+23.0%) |
Sept 2013 | - | $1.63 B(+13.3%) | $4.55 B(+1.8%) |
June 2013 | - | $1.44 B(+61.7%) | $4.47 B(-14.6%) |
Mar 2013 | - | $891.00 M(+51.8%) | $5.23 B(+1.2%) |
Dec 2012 | $5.17 B(+13.5%) | $587.00 M(-62.1%) | $5.17 B(-13.0%) |
Sept 2012 | - | $1.55 B(-29.6%) | $5.94 B(+13.4%) |
June 2012 | - | $2.20 B(+166.1%) | $5.24 B(+17.8%) |
Mar 2012 | - | $828.00 M(-39.1%) | $4.45 B(-2.2%) |
Dec 2011 | $4.55 B(-12.6%) | $1.36 B(+60.2%) | $4.55 B(-9.3%) |
Sept 2011 | - | $849.00 M(-39.9%) | $5.02 B(-6.1%) |
June 2011 | - | $1.41 B(+51.9%) | $5.34 B(+0.5%) |
Mar 2011 | - | $930.00 M(-49.1%) | $5.32 B(+2.1%) |
Dec 2010 | $5.21 B(-10.3%) | $1.83 B(+55.4%) | $5.21 B(+2.9%) |
Sept 2010 | - | $1.18 B(-15.3%) | $5.06 B(-11.7%) |
June 2010 | - | $1.39 B(+69.4%) | $5.73 B(-2.6%) |
Mar 2010 | - | $819.00 M(-51.2%) | $5.88 B(+1.3%) |
Dec 2009 | $5.81 B(+9.2%) | $1.68 B(-9.0%) | $5.81 B(+8.6%) |
Sept 2009 | - | $1.84 B(+19.8%) | $5.35 B(+13.0%) |
June 2009 | - | $1.54 B(+107.5%) | $4.73 B(+1.9%) |
Mar 2009 | - | $742.00 M(-39.1%) | $4.65 B(-12.6%) |
Dec 2008 | $5.32 B(+28.6%) | $1.22 B(-1.0%) | $5.32 B(-1.4%) |
Sept 2008 | - | $1.23 B(-15.3%) | $5.39 B(-0.9%) |
June 2008 | - | $1.45 B(+3.0%) | $5.44 B(+9.4%) |
Mar 2008 | - | $1.41 B(+9.0%) | $4.98 B(+20.4%) |
Dec 2007 | $4.13 B(-0.9%) | $1.30 B(+1.1%) | $4.13 B(+11.9%) |
Sept 2007 | - | $1.28 B(+29.8%) | $3.70 B(+2.4%) |
June 2007 | - | $988.00 M(+73.9%) | $3.61 B(-4.5%) |
Mar 2007 | - | $568.00 M(-33.8%) | $3.78 B(-9.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2006 | $4.17 B(+3.1%) | $858.00 M(-28.3%) | $4.17 B(-0.1%) |
Sept 2006 | - | $1.20 B(+3.4%) | $4.18 B(-1.1%) |
June 2006 | - | $1.16 B(+20.9%) | $4.22 B(+3.6%) |
Mar 2006 | - | $958.00 M(+10.9%) | $4.08 B(+0.8%) |
Dec 2005 | $4.04 B(+71.3%) | $864.00 M(-30.5%) | $4.04 B(+1.3%) |
Sept 2005 | - | $1.24 B(+22.8%) | $3.99 B(+13.3%) |
June 2005 | - | $1.01 B(+9.4%) | $3.53 B(+7.7%) |
Mar 2005 | - | $925.00 M(+13.6%) | $3.27 B(+38.6%) |
Dec 2004 | $2.36 B(+6.8%) | $814.00 M(+5.0%) | $2.36 B(+1.8%) |
Sept 2004 | - | $775.00 M(+2.1%) | $2.32 B(+28.5%) |
June 2004 | - | $759.00 M(+5738.5%) | $1.81 B(+5.6%) |
Mar 2004 | - | $13.00 M(-98.3%) | $1.71 B(-22.6%) |
Dec 2003 | $2.21 B(+39.0%) | $773.00 M(+196.7%) | $2.21 B(+10.5%) |
Sept 2003 | - | $260.50 M(-60.8%) | $2.00 B(+9.0%) |
June 2003 | - | $663.90 M(+29.5%) | $1.83 B(+8.1%) |
Mar 2003 | - | $512.60 M(-9.0%) | $1.70 B(+6.8%) |
Dec 2002 | $1.59 B(+53.1%) | $563.20 M(+494.1%) | $1.59 B(+11.9%) |
Sept 2002 | - | $94.80 M(-82.0%) | $1.42 B(-5.5%) |
June 2002 | - | $527.10 M(+30.2%) | $1.50 B(+23.8%) |
Mar 2002 | - | $404.90 M(+2.7%) | $1.21 B(+17.0%) |
Dec 2001 | $1.04 B(-13.2%) | $394.20 M(+121.8%) | $1.04 B(+15.9%) |
Sept 2001 | - | $177.70 M(-25.3%) | $896.20 M(-25.1%) |
June 2001 | - | $238.00 M(+4.2%) | $1.20 B(-2.3%) |
Mar 2001 | - | $228.50 M(-9.3%) | $1.22 B(+2.2%) |
Dec 2000 | $1.20 B(+55.2%) | $252.00 M(-47.2%) | $1.20 B(+14.7%) |
Sept 2000 | - | $477.30 M(+79.6%) | $1.04 B(+27.1%) |
June 2000 | - | $265.80 M(+31.7%) | $820.60 M(-3.3%) |
Mar 2000 | - | $201.80 M(+105.1%) | $848.50 M(+10.0%) |
Dec 1999 | $771.10 M(+21.7%) | $98.40 M(-61.4%) | $771.10 M(-10.8%) |
Sept 1999 | - | $254.60 M(-13.3%) | $864.90 M(+11.9%) |
June 1999 | - | $293.70 M(+136.1%) | $772.80 M(+30.4%) |
Mar 1999 | - | $124.40 M(-35.3%) | $592.70 M(-6.5%) |
Dec 1998 | $633.70 M(+23.0%) | $192.20 M(+18.3%) | $633.70 M(+8.7%) |
Sept 1998 | - | $162.50 M(+43.0%) | $583.00 M(+12.3%) |
June 1998 | - | $113.60 M(-31.3%) | $519.20 M(-5.8%) |
Mar 1998 | - | $165.40 M(+16.9%) | $550.90 M(+7.0%) |
Dec 1997 | $515.10 M(-7.3%) | $141.50 M(+43.4%) | $515.10 M(-6.5%) |
Sept 1997 | - | $98.70 M(-32.1%) | $551.10 M(+4.4%) |
June 1997 | - | $145.30 M(+12.1%) | $528.00 M(-16.8%) |
Mar 1997 | - | $129.60 M(-27.0%) | $634.50 M(+14.2%) |
Dec 1996 | $555.70 M(-9.0%) | $177.50 M(+134.8%) | $555.70 M(+1.5%) |
Sept 1996 | - | $75.60 M(-70.0%) | $547.30 M(-10.2%) |
June 1996 | - | $251.80 M(+395.7%) | $609.50 M(+15.0%) |
Mar 1996 | - | $50.80 M(-70.0%) | $530.00 M(-13.2%) |
Dec 1995 | $610.50 M(+52.2%) | $169.10 M(+22.7%) | $610.50 M(+3.8%) |
Sept 1995 | - | $137.80 M(-20.0%) | $588.40 M(+6.4%) |
June 1995 | - | $172.30 M(+31.2%) | $552.90 M(+22.1%) |
Mar 1995 | - | $131.30 M(-10.7%) | $452.70 M(+12.9%) |
Dec 1994 | $401.10 M(+79.8%) | $147.00 M(+43.7%) | $401.10 M(+0.8%) |
Sept 1994 | - | $102.30 M(+41.9%) | $397.80 M(-0.9%) |
June 1994 | - | $72.10 M(-9.5%) | $401.30 M(+6.8%) |
Mar 1994 | - | $79.70 M(-44.5%) | $375.80 M(+68.4%) |
Dec 1993 | $223.10 M(+205.6%) | $143.70 M(+35.8%) | $223.10 M(+121.8%) |
Sept 1993 | - | $105.80 M(+127.0%) | $100.60 M(+1664.9%) |
June 1993 | - | $46.60 M(-163.8%) | $5.70 M(-141.6%) |
Mar 1993 | - | -$73.00 M(-444.3%) | -$13.70 M(-118.8%) |
Dec 1992 | $73.00 M(-28.7%) | $21.20 M(+94.5%) | $73.00 M(+40.9%) |
Sept 1992 | - | $10.90 M(-59.9%) | $51.80 M(+26.7%) |
June 1992 | - | $27.20 M(+98.5%) | $40.90 M(+198.5%) |
Mar 1992 | - | $13.70 M(-141.1%) | $13.70 M(-126.7%) |
Dec 1991 | $102.40 M(-299.2%) | - | - |
Mar 1991 | - | -$33.30 M(-27.0%) | -$51.40 M(+715.9%) |
Mar 1991 | -$51.40 M(+102.4%) | - | - |
Dec 1990 | - | -$45.60 M(+744.4%) | -$6.30 M(-117.3%) |
Sept 1990 | - | -$5.40 M(-116.4%) | $36.40 M(+118.0%) |
June 1990 | - | $32.90 M(+178.8%) | $16.70 M(-165.7%) |
Mar 1990 | -$25.40 M(-48.3%) | $11.80 M(-506.9%) | -$25.40 M(-31.7%) |
Dec 1989 | - | -$2.90 M(-88.4%) | -$37.20 M(+8.5%) |
Sept 1989 | - | -$25.10 M(+172.8%) | -$34.30 M(+272.8%) |
June 1989 | - | -$9.20 M | -$9.20 M |
Mar 1989 | -$49.10 M | - | - |
FAQ
- What is Amgen annual free cash flow?
- What is the all time high annual FCF for Amgen?
- What is Amgen annual FCF year-on-year change?
- What is Amgen quarterly free cash flow?
- What is the all time high quarterly FCF for Amgen?
- What is Amgen quarterly FCF year-on-year change?
- What is Amgen TTM free cash flow?
- What is the all time high TTM FCF for Amgen?
- What is Amgen TTM FCF year-on-year change?
What is Amgen annual free cash flow?
The current annual FCF of AMGN is $7.36 B
What is the all time high annual FCF for Amgen?
Amgen all-time high annual free cash flow is $10.56 B
What is Amgen annual FCF year-on-year change?
Over the past year, AMGN annual free cash flow has changed by -$1.43 B (-16.23%)
What is Amgen quarterly free cash flow?
The current quarterly FCF of AMGN is $3.31 B
What is the all time high quarterly FCF for Amgen?
Amgen all-time high quarterly free cash flow is $3.84 B
What is Amgen quarterly FCF year-on-year change?
Over the past year, AMGN quarterly free cash flow has changed by +$802.00 M (+31.93%)
What is Amgen TTM free cash flow?
The current TTM FCF of AMGN is $6.28 B
What is the all time high TTM FCF for Amgen?
Amgen all-time high TTM free cash flow is $10.87 B
What is Amgen TTM FCF year-on-year change?
Over the past year, AMGN TTM free cash flow has changed by -$3.10 B (-33.01%)